Current identified prognostic factors in pancreatic cancer survival include tumor-staging characteristics such as size [20] and resectability [21], patient physiologic factors such as frailty and/or sarcopenia [22,23], and molecular markers including KRAS, BRCA, TP53, ADAM9 [9] and MSI [24] status. Here, KRAS is linked to pancreatic neoplasm.